PHARMOS CORP General and Administrative Expense
PHARMOS CORP reported General and Administrative Expense of $243.17 thousand for the 3-month period ending 2012-09-30, per its 10-Q filed 2012-11-19.
Discontinued › Expense Statement › Operating Expenses
us-gaap:GeneralAndAdministrativeExpense · last filed 2012-11-19
- PHARMOS CORP general and administrative expense for the quarter ending 2012-09-30 was $243.17K, a 0.59% decline year-over-year.
- PHARMOS CORP general and administrative expense for the quarter ending 2012-06-30 was $237.75K, a 8.35% decline year-over-year.
- PHARMOS CORP general and administrative expense for the quarter ending 2012-03-31 was $260.06K, a 11.65% decline year-over-year.
- PHARMOS CORP general and administrative expense for the quarter ending 2011-12-31 was $207.19K, a 17.65% decline year-over-year.
- PHARMOS CORP general and administrative expense for fiscal 2011 was $1.01M, a 15.31% decline from fiscal 2010.
- PHARMOS CORP general and administrative expense for fiscal 2010 was $1.19M.
| Period end | General and Administrative Expense 3 month | General and Administrative Expense 6 month | General and Administrative Expense 9 month | General and Administrative Expense 12 month |
|---|---|---|---|---|
| 2012-09-30 | $243.17K 10-Q · filed 2012-11-19 | $480.92K derived: sum of 2 quarters · filed 2012-11-19 | $740.98K 10-Q · filed 2012-11-19 | $948.16K derived: sum of 4 quarters · filed 2012-11-19 |
| 2012-06-30 | $237.75K 10-Q · filed 2012-07-30 | $497.81K 10-Q · filed 2012-07-30 | $704.99K derived: sum of 3 quarters · filed 2012-07-30 | $949.60K derived: sum of 4 quarters · filed 2012-11-19 |
| 2012-03-31 | $260.06K 10-Q · filed 2012-04-16 | $467.24K derived: sum of 2 quarters · filed 2012-04-16 | $711.85K derived: sum of 3 quarters · filed 2012-11-19 | $971.26K derived: sum of 4 quarters · filed 2012-11-19 |
| 2011-12-31 | $207.19K derived: 10-K/A 12 month − 10-Q 9 month · filed 2012-02-21 | $451.79K derived: sum of 2 quarters · filed 2012-11-19 | $711.20K derived: sum of 3 quarters · filed 2012-11-19 | $1.01M 10-K/A · filed 2012-02-21 |
| 2011-09-30 | $244.60K 10-Q · filed 2012-11-19 | $504.02K derived: sum of 2 quarters · filed 2012-11-19 | $798.36K 10-Q · filed 2012-11-19 | $1.05M derived: sum of 4 quarters · filed 2012-11-19 |
| 2011-06-30 | $259.42K 10-Q · filed 2012-07-30 | $553.76K 10-Q · filed 2012-07-30 | $805.35K derived: sum of 3 quarters · filed 2012-07-30 | $1.10M derived: sum of 4 quarters · filed 2012-07-30 |
| 2011-03-31 | $294.35K 10-Q · filed 2012-04-16 | $545.94K derived: sum of 2 quarters · filed 2012-04-16 | $841.87K derived: sum of 3 quarters · filed 2012-04-16 | $1.14M derived: sum of 4 quarters · filed 2012-04-16 |
| 2010-12-31 | $251.59K derived: 10-K/A 12 month − 10-Q 9 month · filed 2012-02-21 | $547.53K derived: sum of 2 quarters · filed 2012-02-21 | $848.02K derived: sum of 3 quarters · filed 2012-02-21 | $1.19M 10-K/A · filed 2012-02-21 |
| 2010-09-30 | $295.94K 10-Q · filed 2011-10-31 | $596.43K derived: sum of 2 quarters · filed 2011-10-31 | $935.74K 10-Q · filed 2011-10-31 | |
| 2010-06-30 | $300.49K 10-Q · filed 2011-08-08 | $639.81K 10-Q · filed 2011-08-08 |